Sunday, 26 May 2019

IPC to support SEARN nation for developing PV programmes

20 February 2018 | News

There are 7 WHO collaborative centres globally in pharmacovigilance and WHO collaborative centre for PV in public health and regulatory services from India will serve as the 8th centre.

Image credit- indiaeducation.net

Image credit- indiaeducation.net

The Indian Pharmacopoeia Commission (IPC), Ghaziabad under the union health ministry has chalked out a plan to support South East Asia Regulatory Network (SEARN) nation countries towards integrating their public health programmes with pharmacovigilance (PV) activities towards drug safety.

Through this initiative, the Central Drugs Standard Control Authority (CDSCO) of India which is also a member of SEARN will help member countries like Bangladesh, Bhutan, Korea, Indonesia, Maldives, Myanmar, Nepal, Sri Lanka, Thailand and Timor to build capacity and enable National Regulatory Authorities of respective nations to fulfill their mandates and safeguard public health.

There are 7 WHO collaborative centres globally in pharmacovigilance and WHO collaborative centre for PV in public health and regulatory services from India will serve as the 8th centre. PC has also been assigned to update information on adverse drug reactions (ADRs) that is being reported in India from across all its centres through Vigiflow software to the UMC in Sweden, which is WHO's collaborating centre for international drug monitoring.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Podcast

 

Survey Box

Will stem cell therapy market witness highest growth in Asia by 2020?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls